A pharmaceutical company targeting unmet clinical needs.

Herantis Pharma was created by a merger of two pharmaceutical companies, Hermo Pharma and Laurantis Pharma.

Pipeline

Overview

Herantis has a product development portfolio focused in areas of unmet clinical need, based on internationally recognized science.

Read More

Notice to convene Herantis Pharma Plc's Extraordinary General Meeting of Shareholders

Notice to convene Herantis Pharma Plc's Extraordinary General Meeting of Shareholders Herantis Pharma Plc Company release 19 October 2017, 4:30…

Read More

Herantis Pharma Plc is planning a directed share issue to a limited number of investors and the company's directors regarding the financing of the Lymfactin Phase 2 clinical study

Herantis Pharma Plc is planning a directed share issue to a limited number of investors and the company's directors regarding…

Read More

Herantis Pharma has initiated patient recruitment and consented first patient in CDNF study in Parkinson's disease

Herantis Pharma has initiated patient recruitment and consented first patient in CDNF study in Parkinson's disease Herantis Pharma Plc Company…

Read More

Investors

Herantis shares are listed on NASDAQ OMX Helsinki First North Finland. Read More

New therapies for a better life.